Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer

Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer: a Retrospective, Multicenter Trial

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05278754

Enrollment

Registered

2022-03-14

Start date

2022-03-12

Completion date

2022-08-12

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Lung Cancer

Keywords

Central Lung Cancer, Cavity, Predictor

Brief summary

This study is a retrospective, multicenter clinical study. The main goal is to identify the risk factors for cavity formation in central-type lung cancer lesions, and to construct a prediction model for cavity formation in central-type lung cancer lesions based on the above risk factors.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age：older than 18 years； 2. Clinical or pathologically confirmed central lung cancer; 3. Lesions without cavities at first diagnosis of central lung cancer; 4. Performed complete laboratory and imaging research at the first diagnosis of the central lung cancer; 5. Patients with cavities formation during follow up, and the cavities were independently confirmed by at least 3 imaging experts; 6. Patients with complete medical records;

Exclusion criteria

1. Patients suffering other malignant tumors; 2. Patients missing the imaging data; 3. Patients missing the clinical data.

Design outcomes

Primary

Measure	Time frame	Description
Formation of cavities in the central lung cancer, assessed up to 18 months.	Time from enrollment to the time of cavities formation, assessed up to 18 months.	Time from enrollment to the time of cavities formation, assessed up to 18 months.

Secondary

Measure	Time frame	Description
Hemoptysis in patients with central lung cancer, assessed up to 18 months.	Time from enrollment to hemoptysis, assessed up to 18 months.	Time from enrollment to hemoptysis, assessed up to 18 months.

Contacts

Primary ContactJianfei Tu, Dr

jianfei1133@163.com13646782878

Backup ContactJingjing Song, Dr

8808s_j996@163.com13615780342

Outcome results